Association of the hemochromatosis gene with pazopanib-induced transaminase elevation in renal cell carcinoma-Reference-Cited by-同舟云学术

Association of the hemochromatosis gene with pazopanib-induced transaminase elevation in renal cell carcinoma

Published:2011-06 Issue:6 Volume:54 Page:1237-1243
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Xu Chun-Fang,Reck Brian H.,Goodman Vicki L.,Xue Zhengyu,Huang Lingkang,Barnes Michael R.,Koshy Beena,Spraggs Colin F.,Mooser Vincent E.,Cardon Lon R.,Pandite Lini N.

Publisher

Elsevier BV

Subject

Hepatology

Reference29 articles.

1. Pazopanib: a novel multitargeted tyrosine kinase inhibitor;Sonpavde;Curr Oncol Rep,2007

2. GlaxoSmithKline. Votrient™ (pazopanib) tablets prescribing information. Available from: .

3. European Medicines Agency. Votrient (pazopanib) authorisation details. Available from: .

4. Phase II study of pazopanib (GW786034) given preoperatively in stage I–II non-small cell lung cancer (NSCLC): a proof-of-concept study;Altorki;Ann Oncol,2008

5. Pazopanib (GW786034) is active in women with advanced Epithelial ovarian, fallopian tube, and peritoneal cancers: results of a phase II study;Friedlander;Ann Oncol,2008

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting FGFR1 by β,β-dimethylacrylalkannin suppresses the proliferation of colorectal cancer in cellular and xenograft models;Phytomedicine;2024-07

2. Real-world data on the management of pazopanib-induced liver toxicity in routine care of renal cell cancer and soft tissue sarcoma patients;Cancer Chemotherapy and Pharmacology;2023-12-17

3. Protective effects of taxifolin on pazopanib-induced liver toxicity: an experimental rat model;Experimental Animals;2021

Review of Adjuvant Therapies in Renal Cell Carcinoma: Evidence to Date

;OncoTargets and Therapy;2020-11

5. Severe hyperglycaemia following pazopanib treatment: The role of drug‐drug‐gene interactions in a patient with metastatic renal cell carcinoma—A case report;Journal of Clinical Pharmacy and Therapeutics;2020-05-05